A Study of SGT-212 Gene Therapy in Friedreich's Ataxia

Clinical trial NCT07180355 · RECRUITING

Trial details

NCT number: NCT07180355
Sponsor: Solid Biosciences Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Friedreich's Ataxia (FA)

Start date: 2025-10-22
Primary completion: 2028-03-21
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.